EBV Related Carcinoma
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC (NCT05166577) | Viracta Therapeutics, Inc. | 2021-10-08 |
| Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours (NCT03923842) | Gruppo Oncologico del Nord-Ovest | 2019-06-30 |
Track EBV Related Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.